About This Event
Boundless Bio (Nasdaq: BOLD), a clinical-stage oncology company interrogating extrachromosomal DNA (ecDNA) biology to deliver transformative therapies to patients with previously intractable oncogene amplified cancers, visits the Nasdaq MarketSite in Times Square.
In honor of the occasion, Zachary Hornby, CEO, rings the Opening Bell.